Voloridge Investment Management
VERA icon

Voloridge Investment Management’s Vera Therapeutics VERA Stock Holding History

Voloridge Investment Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-155,829
Closed -$3.67M – 1409
2025
Q2 		$3.67M Buy
+155,829
New +$3.5M 0.01% 835
2024
Q4 		– Sell
-73,141
Closed -$3.23M – 1399
2024
Q3 		$3.23M Sell
73,141
-367,698
-83% -$14M 0.01% 862
2024
Q2 		$15.9M Sell
440,839
-6,066
-1% -$241K 0.06% 448
2024
Q1 		$19.3M Buy
446,905
+430,144
+2,566% +$15.3M 0.07% 338
2023
Q4 		$258K Sell
16,761
-52,910
-76% -$672K ﹤0.01% 1092
2023
Q3 		$955K Buy
+69,671
New +$1.2M ﹤0.01% 1105

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management's VERA Position: Q3 2025 in Review

Voloridge Investment Management sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 155,829 shares — an estimated $3.67M sold.

Voloridge Investment Management first reported a position in VERA in Q3 2023 and held it in 6 quarters. The position peaked at $19.3M in Q1 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Voloridge Investment Management reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 155,829 Vera Therapeutics shares in Q3 2025, an estimated $3.67M.
  • Voloridge Investment Management first reported a position in Vera Therapeutics in Q3 2023 and held it in 6 quarters.
  • Voloridge Investment Management's Vera Therapeutics position peaked at $19.3M in Q1 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.